The Impact of the Systemic Immune-inflammation Index and the Systemic Inflammatory Response Index on Progression-free Survival and Overall Survival in Second-line Immunotherapy for Metastatic Non-small Cell Lung Cancer
The Impact of the Systemic Immune-inflammation Index and the Systemic Inflammatory Response Index on Progression-free Survival and Overall Survival in Second-line Immunotherapy for Metastatic Non-small Cell Lung Cancer - Bagcilar Medical Bulletin
Authors
- Burçin Çakan Demirel (ORCID: https://orcid.org/0000-0003-0734-0692)
- Atike Gökçen Demiray (ORCID: https://orcid.org/0000-0003-4397-5468)
- Şahin Bedir (ORCID: https://orcid.org/0000-0002-5797-0804)
- Melek Özdemir (ORCID: https://orcid.org/0000-0003-1894-9743)
- Jamshid Hamdard (ORCID: https://orcid.org/0000-0002-5823-1704)
- Semra Taş (ORCID: https://orcid.org/0000-0002-9441-9210)
- Aynur Özen
- Ahmet Bilici
Publication Details
- Journal
- Bagcilar Medical Bulletin
- Published
- 2026-02-24
- DOI
- https://doi.org/10.4274/bmb.galenos.2026.70299
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00